Guidance on contraception for women aged over 40 years.
Summary of "Guidance on contraception for women aged over 40 years."
No Summary Available
Richard-Wagner-Strasse 10, 68649 Gross-Rohrheim, Germany; email@example.com.
This article was published in the following journal.
Name: The journal of family planning and reproductive health care / Faculty of Family Planning & Reproductive Health Care, Royal Colle
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/21454281
- DOI: http://dx.doi.org/10.1136/jfprhc.2011.0065
Medical and Biotech [MESH] Definitions
Purplish or brownish red discoloration of the skin associated with increase in circulating polyclonal globulins, usually GAMMA-GLOBULINS. This syndrome often occurs on the legs of women aged 20 to 40 years.
A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.
The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
Aged, 80 And Over
A person 80 years of age and older.
Methods of contraception in which physical, chemical, or biological means are used to prevent the SPERM from reaching the fertilizable OVUM.
Around 25% of women in the UK aged 16-49 years use oral contraception.1 Annually, around 5 million combined oral contraceptive (COC) items are prescribed in primary care in England alone, at a cost of...
OBJECTIVES: This study reports on current information sources of women with Congenital Heart Disease (CHD) regarding sexuality, pregnancy and contraception. STUDY DESIGN: 536 women with CHD, aged 29 ...
Migraine is highly prevalent in women, particularly in the reproductive years when contraception may be needed. Preventive strategies are known to be underutilized for migraine. Women of reproductive...
Objectives To analyse the acceptability and patterns of use of the levonorgestrel releasing-intrauterine system (LNG-IUS) and the etonogestrel releasing-subdermal implant (ENG implant) among young Eur...
OBJECTIVE: Studies suggest that not all patients desire shared decision making, and little is known about decision making around contraception. This study compared decision-making preferences for cont...
In this study, 66 HIV-infected women who desire contraception will be randomly assigned to use either an IUD or Depo Provera, and will be followed for six months. The study is intended to...
This project seeks to demonstrate that computer kiosks in a clinic waiting room can improve access to hormonal contraception and screening for sexually transmitted infections. The study wi...
Depot medroxyprogesterone acetate (DepoProvera) is an acceptable form of contraception for many women. However, difficulty in access may cause many women to discontinue use, often without...
A study to determine the efficacy of MK0476 in the Treatment of Asthmatic Patients Aged 2 to 5 Years.
A randomized trial of the intrauterine contraceptive device (IUD) versus user's choice hormonal contraception (injectable progestins or oral contraceptive pills) among HIV-infected, recent...